DVL Expands Robotics Strategy into Next-Gen Exoskeletons
| Stock | Dorsavi Ltd (DVL.ASX) |
|---|---|
| Release Time | 28 Apr 2026, 9:04 a.m. |
| Price Sensitive | Yes |
DVL Expands Robotics Strategy into Next-Gen Exoskeletons
- Exoskeleton systems identified as priority application
- Proprietary motion sensing as intelligence layer
- RRAM and neuromorphic program directly applicable
dorsaVi Ltd (ASX: DVL) is pleased to announce it has identified next generation exoskeleton systems as a strategic application pathway for the Company's existing sensor intelligence platform and its RRAM based neuromorphic semiconductor development programme. The Company sees exoskeletons as the first of several high value human movement adjacent application areas within the broader human-robot collaboration space that DVL intends to address. The Company is formally exploring commercial opportunities in the exoskeleton intelligence space, with an initial focus on three high value application areas: exoskeleton intelligence layers, human-in-the-loop robotic control, and fatigue aware robotics. The underlying technology stack being developed for exoskeleton systems, encompassing real-time human sensing, biomechanical analytics, and neuromorphic edge compute, has significant applicability across the wider collaborative robotics market, including industrial cobots, autonomous mobile robots, and surgical robotics. The global exoskeleton market was valued at US$590 million in 2025 and is projected to reach ~US$2 billion by 2033, driven by adoption across healthcare, defence, industrial and rehabilitation applications. The Company has also completed the acquisition of neuromorphic and in-memory processing intellectual property from one of the world's foremost research universities in electrical engineering, computer science and nanotechnology, which strengthens dorsaVi's proprietary IP portfolio in processing-in-memory and neuromorphic computing architectures.
The global exoskeleton market is projected to reach ~USD 2 billion by 2033.
dorsaVi is shifting from being a sensor company to providing the essential intelligence layer that allows advanced machinery to synchronise with human intent. The market opportunity is immense, and dorsaVi is uniquely positioned to execute on this roadmap that transitions its clinical-grade diagnostics into a scalable robotic control engine.